Results 31 to 40 of about 9,067 (180)

A lateral flow immunoassay for the rapid identification of Candida auris from isolates or directly from surveillance enrichment broths

open access: yesFrontiers in Microbiology
IntroductionCandida auris is a recently discovered yeast with a multi-drug resistant profile associated with high mortality rates. The rapid identification of Candida auris in hospital settings is crucial to allow appropriate therapeutic and rapid ...
Arnaud Chalin   +6 more
doaj   +1 more source

Candida auris and endogenous panophthalmitis: clinical and histopathological features

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: To report an unusual case of endogenous panophthalmitis involving Candida auris and describe its clinical and histopathological features. Findings: A 30 year-old man with history of human immunodeficiency virus, polysubstance abuse, syphilis ...
Mark P. Breazzano   +5 more
doaj   +1 more source

Antifungal Activity of a Medical-Grade Honey Formulation against Candida auris

open access: yesJournal of Fungi, 2021
Candida auris is a pathogenic yeast causing outbreaks in intensive care units with high mortality rates. The treatment of C. auris colonization is challenging due to high resistance rates.
Theun de Groot   +5 more
doaj   +1 more source

Biofilm-forming fluconazole-resistant Candida auris causing vulvovaginal candidiasis in an immunocompetent patient: A case report

open access: yesAsian Pacific Journal of Tropical Medicine, 2021
Rationale: Candida auris is a potential emerging pathogen among Candida and causes serious health threats globally. Patient concerns: We reported a case of vulvovaginal candidiasis caused by Candida auris.
Lakshmi Krishnasamy   +3 more
doaj   +1 more source

Candida auris: an Emerging Fungal Pathogen [PDF]

open access: yesJournal of Clinical Microbiology, 2018
ABSTRACT Candida auris has emerged globally as a multidrug-resistant health care-associated fungal pathogen. Recent reports highlight ongoing challenges due to organism misidentification, high rates of antifungal drug resistance, and significant patient mortality.
Emily S, Spivak, Kimberly E, Hanson
openaire   +2 more sources

Candida auris: Diagnostic challenges and outbreak control in paediatric and neonatal intensive care unit in a tertiary care hospital - the first of many in Eastern India

open access: yesClinical Epidemiology and Global Health
Problem considered: An emerging global threat, Candida auris infections have poor prognosis, high transmission rate, and potential for outbreaks. In India, prevalence of Candida auris invasive infection has been calculated to be 5.3 %.
K.P. Anirima   +5 more
doaj   +1 more source

Differential skin immune responses in mice intradermally infected with Candida auris and Candida albicans

open access: yesMicrobiology Spectrum, 2023
Candida auris, an emerging multi-drug-resistant fungal pathogen, uniquely colonizes the human skin long term, leading to subsequent development of life-threatening invasive infections in humans. The factors regulating skin colonization of C.
Abhishek Datta   +5 more
doaj   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016–2017

open access: yesEmerging Infectious Diseases, 2019
Candida auris is an invasive healthcare-associated fungal pathogen. Cases of candidemia, defined as illness in patients with Candida cultured from blood, were detected through national laboratory-based surveillance in South Africa during 2016–2017.
Erika van Schalkwyk   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy